Katherine V Houser
7PUBLICATIONS
42CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Sep 17, 2024
Phase 1 dose-escalation trial evaluating a group 2 influenza hemagglutinin stabilized stem nanoparticle vaccine.Joseph P Casazza, Amelia R Hofstetter, Pamela J M Costner
|Mar 30, 2024
Heterologous cAd3-Ebola and MVA-EbolaZ vaccines are safe and immunogenic in US and Uganda phase 1/1b trials.Myra Happe, Amelia R Hofstetter, Jing Wang
|Apr 19, 2023
An influenza hemagglutinin stem nanoparticle vaccine induces cross-group 1 neutralizing antibodies in healthy adults.Alicia T Widge, Amelia R Hofstetter, Katherine V Houser
|Apr 19, 2023
An influenza H1 hemagglutinin stem-only immunogen elicits a broadly cross-reactive B cell response in humans.Sarah F Andrews, Lauren Y Cominsky, Geoffrey D Shimberg
|Feb 04, 2022
A single residue in influenza virus H2 hemagglutinin enhances the breadth of the B cell response elicited by H2 vaccination.Sarah F Andrews, Julie E Raab, Jason Gorman
|Feb 04, 2022
Safety and immunogenicity of a ferritin nanoparticle H2 influenza vaccine in healthy adults: a phase 1 trial.Katherine V Houser, Grace L Chen, Cristina Carter
Pageof 2
Frequent Collaborators
5 joint publications
Masaru Kanekiyo
5 joint publications
Sarah F Andrews
5 joint publications
Adrian B McDermott
4 joint publications
Amelia R Hofstetter
4 joint publications
Rebecca A Gillespie
4 joint publications
Adrian Creanga
3 joint publications
Lesia K Dropulic
2 joint publications
Tongqing Zhou
2 joint publications
Raffael Nachbagauer
2 joint publications
Peter Palese
